Previous observational studies have demonstrated positive associations between smoking patterns and the prevalence of acne and rosacea. However, the possible causal relationship remained unclear. Therefore, we conducted a Mendelian randomization (MR) study to investigate the potential causal association between smoking and these two common chronic inflammatory skin disorders. The summary statistics dataset related to smoking initiation and smoking behaviors were gathered from the published Genome-wide association study (GWAS) of 462,690 participants in the UK Biobank. The genetic variants associated with acne and rosacea were also obtained from the published GWAS of the FinnGen consortium which included 7,072,771 and 20,169,986 SNPs, respectively. Using these data, we conducted a two-sample MR analysis to determine the causal relationship between smoking behaviors and acne and rosacea. Our results show that lifetime smoking is significantly associated with a higher risk of acne (beta = 0.23, 95%; CI = (0.03, 0.43), SE = 0.10, Pbeta =0.02). Heterogeneity and pleiotropy tests revealed no evidence of heterogeneity or pleiotropy. However, no significant association was observed between smoking initiation and the risk of acne (beta = 0.02, 95%; CI (0.12, 0.14), SE = 0.073, Pbeta =0.71) (MR–Egger intercept = 0.013, P-value = 0.15). Despite no signs of pleiotropy, evidence of heterogeneity was found. Regarding rosacea, our findings determine a significant correlation between smoking behaviors, including smoking initiation and lifetime smoking, and an elevated risk of rosacea (beta = 0.34; 95% CI (0.11, 1.47), SE = 0.15, Pbeta= 0.02) (beta = 0.79; 95% CI (0.11, 1.47), SE = 0.34, Pbeta= 0.02). No evidence of heterogeneity or pleiotropy was also observed. Our study suggests a causal relationship between smoking behaviors and both acne and rosacea. These findings can be beneficial in terms of providing additional perspectives on healthcare decision policies.